|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.98 USD | +0.52% |
|
-0.04% | +6.98% |
| May. 06 | Lendway Names Elizabeth McShane CFO | MT |
| Apr. 26 | Cytokinetics Appoints Sung Lee as CFO | MT |
| Entry price | Target | Stop-loss | Potential |
|---|---|---|---|
| $41.2 | $51 | $38 | +23.79% |
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Its low valuation, with P/E ratio at 8.93 and 7.52 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● For the last few months, analysts have been revising downwards their earnings forecast.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.98% | 19.58B | |
| -0.91% | 120B | |
| +5.10% | 97.09B | |
| +14.83% | 68.89B | |
| +21.34% | 64.27B | |
| +13.24% | 44.08B | |
| +14.31% | 43.02B | |
| +22.68% | 36.47B | |
| +8.42% | 26.16B | |
| -0.40% | 23.24B |
PRINCIPAL FINANCIAL GROUP, INC. 
